| P2093 | author name string | X Wang | |
| | B Wang | |
| | X Xie | |
| | H Zhang | |
| | M Zhang | |
| | D Chen | |
| | X Sun | |
| | H Chen | |
| | Y Chen | |
| | L Wei | |
| | B Jia | |
| | Y Kong | |
| | H Zeng | |
| | G He | |
| P2860 | cites work | Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells | Q42235385 |
| | Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells | Q44249273 |
| | The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury | Q45037623 |
| | Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice | Q45163956 |
| | Association of tumor-associated fibroblasts with progression of hepatocellular carcinoma. | Q50883910 |
| | Increase in CD14+HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis. | Q50909590 |
| | Recruitment of a myeloid cell subset (CD11b/Gr1mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis* | Q60375603 |
| | CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers | Q79674004 |
| | Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 |
| | Analyzing real-time PCR data by the comparative C(T) method | Q28131831 |
| | A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells | Q33335471 |
| | Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. | Q33474008 |
| | Interleukin-6 induces Gr-1+CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in mice | Q33843364 |
| | Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality | Q34648541 |
| | Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway | Q34694101 |
| | CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice | Q35528287 |
| | Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma | Q35889547 |
| | The role of tumor stroma in the interaction between tumor and immune system | Q36070711 |
| | CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function | Q36204706 |
| | Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma | Q36298565 |
| | CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential | Q36583985 |
| | Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma | Q36625697 |
| | Hepatic microenvironment programs hematopoietic progenitor differentiation into regulatory dendritic cells, maintaining liver tolerance. | Q36941065 |
| | Human hepatic stellate cells inhibit T-cell response through B7-H1 pathway | Q36966364 |
| | Tumor escape mechanism governed by myeloid-derived suppressor cells | Q37138881 |
| | Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma | Q37248887 |
| | The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression | Q37253328 |
| | Chemokine-directed immune cell infiltration in acute and chronic liver disease | Q37345875 |
| | Tumor microenvironment and myeloid-derived suppressor cells | Q38067642 |
| | History of myeloid-derived suppressor cells | Q38141522 |
| | Stellate cells and the development of liver cancer: therapeutic potential of targeting the stroma | Q38188317 |
| | Targeting the tumor stroma in hepatocellular carcinoma | Q38366586 |
| | Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model | Q39051077 |
| | Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma | Q39326402 |
| | Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. | Q39901596 |
| | Liver stroma enhances activation of TLR3-triggered NK cells through fibronectin | Q39995686 |
| | Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. | Q39997114 |
| | B7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells | Q41342548 |
| | Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells | Q41376824 |
| | TLR2 limits development of hepatocellular carcinoma by reducing IL18-mediated immunosuppression | Q41534407 |
| P433 | issue | 1 | |
| P304 | page(s) | 96-108 | |
| P577 | publication date | 2016-12-26 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver | |
| P478 | volume | 188 | |